glp-1 long-term safety The question we get asked more than any other — is actually safe long term? 👀 The answer isn't a simple yes or no. It depends on the research, the supervision Long Term GLP-1 Use: Maintenance

Recall announcements and warnings are simplified to improve clarity and accessibility

Their therapeutic potential is evident in various disease contexts, including type 2 diabetes, neurodegenerative disorders, and inflammatory bowel disease (IBD)

Both, SGLT2 inhibitors and GLP1 receptor agonists, had similar effect on MACE reduction, but SGLT2 inhibitors have far more benefits in patients with heart failure

When to Seek Medical Advice About GLP-1 Side Effects Whilst mild, transient fatigue is relatively common during the initial phases of GLP-1 therapy, certain warning signs warrant prompt medical review

Committee Opinion No